Anticonvulsants are medications that prevent or stop seizures by calming excessive electrical activity in the brain. Originally developed for epilepsy, they’re now widely prescribed for conditions ranging from bipolar disorder to chronic nerve pain. More than 20 anticonvulsants are currently available, and while none of the newer options have proven more effective at stopping seizures than older drugs, they generally cause fewer side effects and are easier to dose safely.
How Anticonvulsants Work
Seizures happen when groups of neurons fire too rapidly and in sync. Anticonvulsants interrupt this process through several mechanisms, and most drugs use more than one at a time.
The most common approach targets sodium channels, the gateways that let electrical signals travel along a nerve cell. Drugs that block these channels extend the “cooldown” period between firings, making it harder for neurons to generate the rapid, repetitive bursts that drive a seizure. A second group works on calcium channels. Certain brain cells, particularly in the thalamus, rely on a specific type of calcium channel to set the rhythm of electrical activity. Blocking these channels disrupts the synchronized firing patterns behind absence seizures, the brief “staring spells” most common in children.
Other anticonvulsants boost the brain’s natural braking system. A chemical messenger called GABA normally slows neural activity down. Some drugs make GABA receptors more sensitive, others prevent GABA from being recycled or broken down, and the net result is stronger inhibition of overactive circuits. A smaller number of drugs work on the opposite side of the equation, reducing the effect of glutamate, the brain’s primary excitatory signal. By dampening glutamate signaling, these medications make neurons less likely to reach the threshold for a seizure.
Uses Beyond Epilepsy
Because anticonvulsants stabilize nerve cell activity in general, not just in epilepsy, they’ve found a place in treating several other conditions. Some of the most common non-epilepsy uses include:
- Bipolar disorder: Certain anticonvulsants have mood-stabilizing properties and are used to manage manic episodes or prevent mood swings.
- Neuropathic pain: Nerve damage from diabetes, shingles, or other causes can produce burning or shooting pain. Several anticonvulsants reduce this by quieting the misfiring nerves responsible.
- Migraine prevention: A couple of anticonvulsants are prescribed to reduce the frequency and severity of migraines when taken daily as a preventive measure.
In many of these cases, the same mechanism that prevents seizures, calming hyperactive neurons, also addresses the underlying problem in pain signaling or mood regulation.
Generations of Anticonvulsants
The history of these drugs stretches back more than 150 years. Potassium bromide was the first medication used for epilepsy, but it had a narrow margin between a helpful dose and a toxic one, and it could cause severe skin reactions, psychosis, and even worsen seizures. Phenobarbital replaced it as a better-tolerated option in the early 1900s, followed by phenytoin in 1938, which was more effective and less sedating than either predecessor. Phenytoin remained the go-to treatment for decades.
A second wave arrived in the 1960s and 1970s with drugs like valproate and carbamazepine. Since the 1990s, at least 18 newer anticonvulsants have reached the market. These newer-generation drugs haven’t made older ones obsolete in terms of seizure control, but they offer meaningfully better safety profiles, fewer drug interactions, and simpler dosing. For many patients, that translates into fewer blood tests and a lower chance of troublesome side effects.
Common Side Effects
Most anticonvulsants share a core set of side effects related to how they slow down neural activity. Drowsiness, dizziness, and difficulty with coordination are the most frequent complaints, especially when starting a new medication or increasing a dose. Some people also experience blurred vision, difficulty concentrating, or unsteadiness when walking.
Rarer but more serious reactions exist. DRESS syndrome is a potentially dangerous drug reaction involving skin rash, elevated levels of certain white blood cells, and organ damage, most often to the liver or kidneys. It’s most closely associated with a handful of older anticonvulsants. If left untreated, it can progress to organ failure or a severe skin condition called toxic epidermal necrolysis. Any new rash, fever, or facial swelling shortly after starting an anticonvulsant warrants immediate medical attention.
Blood Monitoring for Certain Drugs
Some older anticonvulsants require periodic blood tests to ensure the drug level in your body stays in a safe, effective range. Phenytoin is the classic example. It has unusually complex pharmacokinetics, meaning a small increase in dose can cause a disproportionately large jump in blood levels, making toxicity hard to predict without lab work. Therapeutic drug monitoring was essentially invented for phenytoin in the 1960s.
Target blood level ranges have been established for several older drugs: phenytoin, phenobarbital, carbamazepine, and valproate all have well-defined windows where seizure control is most likely and side effects are least likely. Newer anticonvulsants generally don’t require routine blood monitoring because their levels in the body scale more predictably with the dose you take. That said, your doctor may still check levels in certain situations, like during pregnancy, when taking multiple medications, or if seizure control changes unexpectedly.
Pregnancy Considerations
Anticonvulsants vary widely in their safety during pregnancy, and this is one of the most actively studied areas in epilepsy care. Valproate poses the highest known risk to a developing fetus and has been the subject of aggressive regulatory action since 2015. Between 2013 and 2021, prenatal valproate exposure dropped by roughly 84% as prescribers shifted to safer alternatives. Carbamazepine and topiramate also carry acknowledged risks, but exposure to these drugs has barely decreased over the same period, with close to 600 newborns still exposed to each per year in recent data.
Lamotrigine and levetiracetam are currently considered the safest options during pregnancy. A large and growing group of newer drugs falls into an “uncertain risk” category simply because there isn’t enough long-term data yet. One concerning trend: prescriptions for pregabalin and gabapentin during pregnancy have risen significantly, with sustained pregabalin exposure throughout pregnancy increasing by 171%, even though their safety profiles in pregnancy aren’t fully established. If you take an anticonvulsant and are considering pregnancy, the choice of medication matters enormously and is worth discussing well before conception.
Why Tapering Matters
Stopping an anticonvulsant abruptly can trigger withdrawal seizures, even in people whose seizures have been well controlled for years. This risk is especially high with benzodiazepines and barbiturates, which cause physical dependence in the nervous system over time. Gradual dose reduction over weeks or months allows the brain to readjust and gives you and your doctor a chance to identify the lowest effective dose in case seizures return.
The speed of tapering depends on several factors: which drug you’re on, your starting dose, how long you’ve been taking it, and how serious a breakthrough seizure would be for you (someone who drives daily, for instance, faces different stakes than someone who doesn’t). During pregnancy, the desire to limit fetal drug exposure can create pressure to stop quickly, but abrupt cessation is still considered dangerous and is avoided even in that context.